Viewing entries tagged
Atherosclerosis Prevention

     

 
   the Particle Problem: Why Your "Normal" Cholesterol Panel is Hiding Your True Cardiovascular Risk 
 




















  
  



    

 
   Translating Dr. Allan Sniderman’s Clinical Lipidology Research on Apolipoprotein B, Discordance,

Comment

The typical lipid profile is measuring the size (weight) of the package not the density of the fleet; cardiovascular risk is determined by total particle exposure over time—area under the curve. The following represents how you can apply ApoB kinetics, endothelial cell invasion, and the two vector approach in order to stop the process of atherosclerosis.

Comment